Stay updated on Semaglutide in Heart Failure & Obesity: Clinical Trial
Sign up to get notified when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.

Latest updates to the Semaglutide in Heart Failure & Obesity: Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded Revision: v3.4.2 to the history and removed the government-funding notice and Revision: v3.4.1 from the history.SummaryDifference0.3%

- Check21 days agoChange DetectedAdded a government funding lapse notice with status guidance and links to cc.nih.gov and opm.gov, and updated the revision from v3.4.0 to v3.4.1 (removing the v3.4.0 entry). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check28 days agoChange DetectedUI updates add a glossary option and color-coded change indicators (green for additions, red for deletions) with display notes; the revision banner shows Revision: v3.4.0 and No FEAR Act data reference was removed (previously Revision: v3.3.4).SummaryDifference0.4%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision tag, v3.3.3, was added to the history, and the HHS Vulnerability Disclosure link along with the previous revision tag v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check78 days agoChange DetectedThe latest version adds updated Contacts/Locations and Study Status. It also removes the 2025-02-26 entry from the history.SummaryDifference0.2%

Stay in the know with updates to Semaglutide in Heart Failure & Obesity: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide in Heart Failure & Obesity: Clinical Trial page.